Pros | ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 3Y returns in the top 25% of the category. ![]() Among most bought funds within the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | ![]() 5Y returns in the bottom 25% of the category. ![]() 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 8/8 | 3/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 5 Years | 6 Years | ||
Fund Size | 755 Cr | 3198 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹100 | ||
Expense Ratio | 1.1% | 0.63% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | S&P BSE Healthcare PR | S&P BSE Healthcare PR |
No of Holdings | 29 | 34 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (14.49%) Cipla Ltd (8.9%) Torrent Pharmaceuticals Ltd (7.6%) Abbott India Ltd (6.56%) Apollo Hospitals Enterprise Ltd (5.93%) | Suven Pharmaceuticals Ltd (10.25%) Sun Pharmaceuticals Industries Ltd (10.13%) Cipla Ltd (8.54%) Ipca Laboratories Ltd (7.37%) Globus Medical Inc Class A (6.39%) | ||
No of Sectors | 2 | 2 | ||
Top 3 Sectors | Health (99.2%) Basic Materials (0.8%) | Health (98.59%) Financial Services (1.41%) | ||
Equity % | 98.62% | 98.27% | ||
Debt % | - | - | ||
P/E | 35.19 | 38.31 | ||
P/B | 5.89 | 4.99 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 5.92% | 3.71% | ||
3-Month Return | -9.74% | -9.86% | ||
6-Month Return | -9.82% | -7.77% | ||
1-Year Return | 9.92% | 15.68% | ||
3-Year Return | 18.34% | 21.2% | ||
5-Year Return | 25.95% | 29.98% |
Sharpe | 0.74 | 0.9 | ||
Alpha | -0.56 | 2.42 | ||
Beta | 0.96 | 0.87 | ||
Standard Deviation | 16.88 | 15.95 | ||
Information Ratio | -0.34 | 0.16 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | DSP Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah | Chirag Dagli |